Axitinib 99% white to tan 319460-85-0
TDS
319460-85-0
Pharmacy Grade
99%
Xinke
foil bag
2022-02-08
Tenofovir alafenamide intermediate,Axitinib,Avatrombopag intermediate,Tenofovir alafenamide hemifumarate,Axitinib intermediate,Lenvatinib intermediate
-
Product Description
-
Seller Information
-
DescriptionCertificatesBasic Info
-
Product Name:
Axitinib
Other Name:Benzamide,N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide;AG 013736;Axitinib;Inlyta;790713-39-2
CAS No.:319460-85-0
Molecular Formula:C22H18N4OS
InChIKeys:InChIKey=RITAVMQDGBJQJZ-FMIVXFBMSA-N
Molecular Weight:386.47
Exact Mass:386.47
EC Number:1308068-626-2
UNII:C9LVQ0YUXG
NSC Number:757441
DSSTox ID:DTXSID3049049
NCI Thesaurus Code:C38718
ATC Code:L01EK01|L01XE17|L - Antineoplastic and immunomodulating agents
HScode:2933990090
Categories:
Characteristics-
PSA:
96
XLogP3:4.2
Appearance:white to tan
Density:1.4±0.1 g/cm3
Melting Point:213-215°C
Boiling Point:668.9°C at 760 mmHg
Flash Point:358.3±31.5 °C
Refractive Index:1.728
Water Solubility:In aqueous media with a pH between 1.1 to 7.8, axitinib has a solubility of over 0.2 μg/mL.DMSO: ≥8mg/mL
Storage Conditions:-20°C Freezer
Dissociation Constants:4.8
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H400 Very toxic to aquatic life
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P273 Avoid release to the environment.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P391 Collect spillage.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tenofovir alafenamide intermediate,Axitinib,Avatrombopag intermediate,Tenofovir alafenamide hemifumarate,Axitinib intermediate,Lenvatinib intermediate
-
Location:
No.108-102,Xinmao Qilu Science city,, Tianqiao district, Jinan City,
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
300
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
